Study finds varenicline can help young adults quit vaping

Varenicline, a smoking cessation drug, can also help young adults quit vaping, according to a study by researchers from Mass General Brigham. The study, Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial, published in JAMA last week, showed that teenagers and young adults who took a varenicline pill twice a day were more than three times as likely to quit vaping as those who received only a text service. For the study, published in the Journal of the American Medical Association last week, researchers recruited 261 participants aged 16‐to‐25 into a randomized clinical trial. There were three groups.